Towards Healthcare
Low-Input Sequencing Technologies Market Size, Emerging Trends and Strategic I...

Low-Input Sequencing Technologies Market Dynamics and AI Powered Innovation Trends

The growing genomics research and technological advancements drive the market. North America dominated the global market owing to state-of-the-art research and development facilities and the presence of key players.

Content

  • Insight Code: 5767
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The market is expected to grow into the hundreds of millions by 2034, driven by strong CAGR in Asia-Pacific and continued dominance in North America

NGS dominates the market due to its ability to handle low sample volumes with high accuracy.

Key areas include consumables, AI-integrated sequencing tools, services for outsourced research, and long-read sequencing technology

AI boosts efficiency by automating workflows, improving accuracy, and enabling real-time data analysis.

The market is dominated by players like Illumina, PacBio, BioSkryb Genomics, and Watchmaker Genomics.

Emerging disruptions include long-read sequencing, single-cell RNA sequencing, CRISPR-based diagnostics, and integration of LinTIMaT with low-input workflows.

Clinical diagnostics, particularly in oncology and rare disease screening, dominate current applications.
Any Questions